In addition to the production and marketing of 30 of its own products, the GMP-certified company has established a second mainstay with contract manufacturing. Depending on the customer's requirements, Dreluso Pharmazeutika takes over the complete range of work steps in the production of medicines and food supplements or offers individual sub-steps such as the packaging of bulk goods in secondary packaging. The portfolio ranges from the complete production of non-sterile liquids to packaging and the associated logistics.

Regardless of the batch size, the complete spectrum of packaging is offered: Folding carton filling with or without inserts, addition of measuring spoons or similar, replacement of inserts or change of pack sizes are just a few examples. In addition, several packaging units can be cellophaned, shrink-wrapped or bundled. Since 2018, the company has also been offering the legally required serialisation of prescription medicines in accordance with Directive 2011/62/EU and the associated regulations.

New hall construction 2020 - sustainable investment in the future

In the summer of 2020, the construction of another hall was started, which was then already inaugurated in the winter of 2020.

Dreluso Pharmazeutika now has an additional 750 square metres of space for the packaging and temperature-controlled storage of semi-finished and finished goods. During the planning phase, the local hall construction company took energy aspects into account. The design of the necessary retention area for surface water as a near-natural area provides new habitats for insects, birds and other small animals in the middle of the industrial estate.

Dreluso Pharmazeutika also sees the investment at its headquarters as a clear commitment to Germany as a production location. International supply chains have become standard in a globalised world and offer numerous advantages. In times of crisis, however, the resilience of these supply chains is put to the test. Dreluso Pharmazeutika has been making a contribution here even before the political drive to re-locate more pharmaceutical industry in Germany or at least in Europe.

Company History:

• 2009 the first contract manufacturing works are carried out
• 2011 turnover of contract manufacturing has doubled
• 2012 purchase of a further production hall due to the development of sales
• 2015 new logo, own homepage and management as profit center "Dreluso Lohnfertigung und Dienstleistungen"
  
  
• 2017 Investment in Serialisation and Tamper Evidence
• 2018 launch of Serialisation and Tamper Evidence
• 2020 construction and commissioning of a new production and storage hall